Porcine Deltacoronavirus: Veterinary Reference

Overview and Taxonomy of Porcine Deltacoronavirus: Veterinary Reference

Porcine deltacoronavirus (PDCoV) represents a relatively novel and economically significant addition to the constellation of swine enteric coronaviruses (SECoVs) that have challenged the global swine industry. First identified in 2012 through a molecular surveillance study in Hong Kong that retrospectively detected the virus in samples collected as early as 2009 [1-3, 8], PDCoV has since emerged as a formidable enteropathogen with a demonstrated capacity for rapid transboundary spread and, alarmingly, interspecies transmission. The virus is classified within the genus Deltacoronavirus, family Coronaviridae, order Nidovirales, a taxonomic grouping that distinguishes it from the more extensively studied Alphacoronavirus genera that contain porcine epidemic diarrhea virus (PEDV) and transmissible gastroenteritis virus (TGEV), as well as the Betacoronavirus genus that includes severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV). The deltacoronaviruses are primarily associated with avian hosts, and the emergence of PDCoV as a mammalian pathogen represents a remarkable and concerning example of cross-species transmission from avian reservoirs, a hypothesis strongly supported by phylogenetic analyses demonstrating that PDCoV shares its closest genetic ancestry with sparrow deltacoronavirus (SpDCoV HKU17) and other avian deltacoronaviruses [8, 15].

The PDCoV virion is enveloped and pleomorphic, with a diameter of approximately 60–180 nm, and contains a single-stranded, positive-sense RNA genome that is approximately 25.4 kb in length, making it the smallest genome among the known coronaviruses [7, 9, 11]. The genomic organization follows the canonical coronavirus architecture: a 5′ untranslated region (UTR) is followed by large open reading frames (ORF1a and ORF1b) encoding nonstructural proteins (nsps) that constitute the replicase-transcriptase complex, and the 3′ third of the genome encodes the canonical structural proteins in the order spike (S), envelope (E), membrane (M), and nucleocapsid (N), interspersed with accessory genes that vary among strains [7, 9]. The S glycoprotein, a trimeric class I fusion protein that decorates the virion surface, is the primary determinant of receptor binding, host tropism, and a major target of neutralizing antibody responses [1, 3, 12]. The N protein, highly conserved and abundantly expressed during infection, plays crucial roles in viral RNA packaging and modulation of host cell signaling and serves as a preferred target for diagnostic antigen detection assays [4, 6, 10].

A defining characteristic of PDCoV that has demanded intense scrutiny is its expansive host range and demonstrated zoonotic potential. Unlike PEDV and TGEV, which are largely restricted to swine, PDCoV has been shown experimentally and through natural surveillance to infect a remarkably broad spectrum of species, including swine, calves, chickens, turkey poults, and, most significantly, humans [1, 8]. The detection of PDCoV in plasma samples from febrile children in Haiti in 2021 provided the first direct evidence of human infection, a finding that elevated PDCoV from a purely veterinary concern to a pathogen with clear pandemic potential and underscored the urgent need for comprehensive surveillance and the development of countermeasures such as vaccines and antivirals [1, 8]. This zoonotic capacity, combined with the virus’s high genetic plasticity and propensity for recombination, positions PDCoV as a pathogen of critical importance to both the WOAH (World Organisation for Animal Health) and public health authorities [8].

The taxonomy and phylogenetic classification of PDCoV have been areas of active and sometimes conflicting research, with multiple classification schemes proposed as the global diversity of the virus has become more fully appreciated. Early phylogenetic analyses, based on limited genomic data, delineated two major lineages that corresponded broadly to geographic origin: lineage 1 comprised predominantly Chinese strains, while lineage 2 encompassed North American strains [1]. However, as surveillance expanded across Asia, North America, and eventually South America and Europe, this binary classification proved insufficient to capture the full complexity of PDCoV genetic diversity [1-3]. A more recent and comprehensive phylogenetic analysis, informed by the growing repository of complete PDCoV genome sequences in GenBank, has refined the taxonomy into two major lineages (lineage 1 and lineage 2), each further subdivided into sublineages: sublineage 1.1 (Chinese strains), sublineage 1.2 (North American strains), sublineage 2.1 (Southeast Asian strains), and sublineage 2.2 (Chinese strains) [1]. This classification is supported not only by phylogenetic topology but also by specific genetic markers: lineage 2 strains characteristically harbor a continuous 6-nucleotide (nt) deletion in the nsp2-coding region and a 9-nt deletion in the nsp3-coding region of ORF1a, molecular signatures that facilitate genotyping [1, 7].

A parallel classification system, proposed by Hsueh and colleagues, organizes PDCoV strains into two major genogroups, G-I and G-II, with G-II further subdivided into G-II-a, G-II-b, and G-II-c based on spike gene and whole-genome phylogenies [2]. The G-II-b subgroup is notable for containing variants predominantly from China, including the Taiwanese strain PDCoV/104-553/TW-2015, which was the first whole-genome characterization of PDCoV from Taiwan and revealed evidence of recombination with other PDCoV genogroups [2]. These multiple, partially overlapping classification systems reflect the rapid evolution of PDCoV and the challenges inherent in developing a unified taxonomic framework for a virus that continues to diversify through mutation and recombination.

The genetic diversity of PDCoV is further amplified by the emergence of novel lineages in specific geographic regions. A comprehensive longitudinal study conducted in Guangxi Province, southern China, from 2020 to 2023 identified a new lineage, designated China 1.3, which Bayesian coalescent analysis suggested began diverging from other Chinese lineages around 2012 [3]. This lineage exhibited a distinctive constellation of mutations, deletions, and insertions in the S, M, and N genes, some of which were shared with the existing China 1.2 lineage, while others represented unique variations, indicating ongoing adaptive evolution [3]. The identification of such novel lineages is of profound epidemiological significance as they may possess altered antigenic properties, transmissibility, or pathogenic potential, potentially compromising the efficacy of existing diagnostic assays or vaccine candidates.

Recombination is a primary driver of genetic diversity and evolutionary success in coronaviruses, and PDCoV is no exception. Multiple studies have documented recombination events across the PDCoV genome, with the nonstructural protein 2 (nsp2), nonstructural protein 3 (nsp3), and spike (S) genes identified as recombination hotspots [1, 3, 9, 12]. The S gene is of particular importance because it encodes the receptor-binding domain (RBD) and is the major target of neutralizing antibodies; recombination in this region can lead to antigenic shifts that facilitate immune evasion and alter host tropism [1, 12]. A notable example is the Chinese strain CHN-HeN06-2022, a novel recombinant that arose from segment exchange between sublineage 1.1 and sublineage 2.1 strains within the nsp2-nsp3 region [1]. Similarly, the CHN-SC2015 strain isolated from Sichuan Province in southwest China was shown to be the product of recombination between the Chinese strain SHJS/SL/2016 and the US strain TT-1115 [9]. These recombination events complicate phylogenetic classification, as individual genomic regions may have distinct evolutionary histories; a strain may cluster with one lineage based on the S gene and a different lineage based on ORF1ab, a phenomenon known as phylogenetic incongruence [12]. The recognition of widespread recombination necessitates the use of full-genome sequencing for definitive genotyping and highlights the limitations of classification schemes based on single genetic loci.

The S gene, beyond its role in recombination analysis, also exhibits a high degree of genetic variability and is under strong positive selective pressure, likely driven by host immune responses. A comprehensive evolutionary analysis identified 14 amino acid sites in the S protein that are under positive selection, with the majority located in regions critical for viral attachment, receptor binding, and membrane fusion [1]. These findings suggest that PDCoV is actively adapting to its hosts, potentially expanding its host range and altering its pathogenic phenotype. In stark contrast, the E, M, and N structural protein genes are generally more conserved across PDCoV strains, with E and M genes showing >99% nucleotide identity among Thai isolates and >98% identity to global reference strains [13]. The N gene is highly conserved and serves as a reliable target for broadly reactive diagnostic assays, including the monoclonal antibody-based competitive ELISA and the quantum dot-based immunochromatographic strip, which have demonstrated excellent sensitivity and specificity in detecting PDCoV antibodies and antigen, respectively [4-6].

The geographic distribution of PDCoV has expanded dramatically since its initial discovery. Following the early detection in Hong Kong and retrospective identification of the S27 strain in Sichuan, China, from 2012, PDCoV was reported in the United States in early 2014, where it caused outbreaks of acute diarrhea in swine farms across multiple states [1, 16]. Retrospective testing of clinical samples submitted to veterinary diagnostic laboratories revealed that PDCoV was present in US swine herds as early as August 2013, predating the official outbreak detection by several months [16]. The virus subsequently spread to South Korea (2014), Thailand (2015), Taiwan (2015), Japan (2016), and Vietnam, Laos, and other Southeast Asian nations [2, 9, 12, 13]. A major milestone in global spread occurred in 2019 with the first detection of PDCoV in South America, specifically in Peru, where whole-genome sequencing confirmed a strain with 99.5% nucleotide identity to a North American reference strain, suggesting a likely introduction via animal movement or contaminated fomites [11, 14]. The continuous emergence of genetically distinct lineages in different geographic regions, such as the Southeast Asia-like strain CHN/GX/1468B/2017 found in China, underscores the dynamic and fluid nature of PDCoV molecular epidemiology [7].

In summary, the overview and taxonomy of PDCoV reveal a virus of remarkable genetic plasticity, broad host tropism, and demonstrated zoonotic potential. The taxonomic framework is evolving from simple geographic lineages to a more nuanced classification encompassing sublineages and genogroups defined by specific genetic markers and phylogenetic relationships. The interplay of mutation, recombination, and positive selection, particularly in the S gene, drives the emergence of novel variants with unpredictable phenotypic properties. This complex and dynamic landscape necessitates a sophisticated taxonomy, continuous global genomic surveillance, and the development of broadly protective vaccines and diagnostic tools to effectively manage the threat posed by PDCoV to both animal and human health.

Molecular Pathogenesis and Spike Protein-Mediated Entry Mechanisms

Porcine deltacoronavirus (PDCoV), a member of the genus Deltacoronavirus within the family Coronaviridae, represents an emerging swine enteropathogen of considerable veterinary and zoonotic concern. Since its initial identification in Hong Kong in 2012, PDCoV has demonstrated a remarkable capacity for rapid global dissemination, causing acute, often severe, gastroenteritis in neonatal piglets and posing a documented risk for cross-species transmission to humans, poultry, and various avian species [1, 3, 8]. The molecular pathogenesis of PDCoV is fundamentally orchestrated by the spike (S) glycoprotein, a large, trimeric class I viral fusion protein that governs the critical early steps of infection: host cell attachment and membrane fusion. A comprehensive understanding of the structural biology, functional domains, receptor interactions, and evolutionary dynamics of the PDCoV S protein is paramount for elucidating the mechanisms of enteric tropism, interspecies transmission, and immune evasion, and for guiding the rational design of antiviral strategies and effective vaccines.

Architecture and Functional Domains of the PDCoV Spike Glycoprotein

The PDCoV S gene encodes a surface-exposed, heavily glycosylated protein that is cleaved by host proteases into two functional subunits: the N-terminal S1 subunit, responsible for receptor binding, and the C-terminal S2 subunit, which mediates membrane fusion. This proteolytic cleavage, a hallmark of many pathogenic coronaviruses, is essential for the activation of the fusion machinery and is a key determinant of tissue tropism and pathogenicity. The S1 subunit contains the receptor-binding domain (RBD), the specific region that engages with the host cell receptor to initiate viral entry. While the exact cognate receptor for PDCoV remains an area of active investigation, compelling evidence suggests that aminopeptidase N (APN), a metalloprotease expressed on the surface of intestinal epithelial cells and other tissues, serves as a primary entry receptor. This is consistent with the enteric tropism of PDCoV and its ability to infect a broad range of species, given the high conservation of APN across mammals and birds. The S2 subunit, following receptor binding and proteolytic priming, undergoes dramatic conformational rearrangements that draw the viral and cellular membranes into close apposition, ultimately leading to fusion and the release of the viral genome into the host cell cytoplasm [1, 9, 17].

Receptor Engagement and Species Tropism

The interaction between the PDCoV S1 RBD and its host receptor is a critical determinant of host range and tissue tropism. The capacity of PDCoV to utilize APN from multiple species, including porcine, human, feline, and avian sources, underpins its documented ability for cross-species transmission. This broad receptor compatibility has been substantiated by epidemiological and experimental evidence demonstrating PDCoV infection in calves, chickens, turkey poults, and, most alarmingly, in human children in Haiti [1, 8]. Phylogenetic analyses have consistently revealed that PDCoV is most closely related to sparrow deltacoronavirus (SpDCoV) HKU17, strongly suggesting an avian origin for the virus and highlighting a past interspecies transmission event from birds to swine [8]. The ongoing evolution of the S gene, driven by selective pressures from host immune responses and adaptation to new species, continues to refine this receptor-binding interface. Genomic surveillance has identified numerous positively selected amino acid sites within the S1 domain, many of which are located in regions directly implicated in viral attachment, receptor binding, and membrane fusion, indicating that the virus is actively fine-tuning its entry machinery for enhanced fitness in various hosts [1, 12].

Proteolytic Activation and Membrane Fusion Machinery

The fusion process mediated by the S2 subunit is a highly coordinated and energetically favorable event. Following receptor engagement, the S protein must be primed by host cell proteases, such as transmembrane protease serine 2 (TMPRSS2) or cathepsins, which cleave the S protein at the S1/S2 boundary and within the S2' site. This cleavage liberates the fusion peptide, a hydrophobic segment within S2 that inserts into the target cell membrane. The subsequent refolding of the S2 subunit involves the formation of a stable six-helix bundle between the heptad repeat 1 (HR1) and heptad repeat 2 (HR2) domains, a process that brings the viral and cellular membranes into close proximity to drive fusion. The specific deletion and insertion signatures frequently observed within the S gene of field isolates, such as the 3-nt deletion in the S gene reported in the CHN-SC2015 strain, may directly influence the efficiency of this fusion process by altering the structural dynamics of the S2 domain, potentially modulating viral fitness, pathogenicity, and cell-to-cell spread [7, 9, 13]. These genetic signatures serve as important markers for tracking the evolution of virulence in circulating strains.

Evolutionary Drivers: Recombination and Positive Selection

The molecular pathogenesis of PDCoV is not static; it is continuously shaped by evolutionary forces. Recombination events, particularly within the S gene, are a major driver of genetic diversity and have been frequently documented among PDCoV strains. The S gene is a recognized recombination hotspot, and the shuffling of genetic material between co-infecting PDCoV lineages, or even with other porcine coronaviruses, can generate novel chimeric viruses with altered antigenic profiles and potentially enhanced pathogenic or zoonotic potential [1-3, 9]. Furthermore, the spike protein is under intense positive selection pressure from the host immune system. The identification of numerous positively selected sites within the S1 and S2 domains directly correlates with regions that interact with neutralizing antibodies or are critical for receptor binding and membrane fusion [1]. These adaptive mutations allow the virus to evade pre-existing immunity, a challenge that must be considered for vaccine development. The continuous emergence of new lineages, such as the China 1.3 lineage described by Li et al. (2024) [3], which exhibits distinct mutations, deletions, and insertions relative to other lineages, underscores the dynamic and ongoing evolution of PDCoV S protein and its central role in viral emergence.

Downstream Consequences: Subversion of Host Cell Stress Responses

The entry of PDCoV and the subsequent replication cycle exert profound effects on the host cell, triggering a complex interplay of cellular stress responses. Viral infection is a potent inducer of the integrated stress response (ISR), a conserved eukaryotic signaling pathway that leads to the phosphorylation of eukaryotic translation initiation factor 2α (eIF2α) and a global shutdown of protein synthesis as an antiviral defense mechanism. However, PDCoV, like other coronaviruses, has evolved sophisticated strategies to subvert this host antiviral pathway to ensure its own replication [18]. The interplay between viral entry, replication, and the manipulation of the host ISR is a critical dimension of PDCoV pathogenesis. The ability of the virus to either suppress or hijack the ISR directly impacts the efficiency of viral protein synthesis and the capacity of the infected cell to mount an effective innate immune response. This intricate host-virus arms race presents a potential vulnerability that can be therapeutically exploited; pharmacological activation of the host ISR using small molecules, such as certain flavonoid compounds, has demonstrated antiviral activity against PDCoV by restoring the antiviral translational block, thereby inhibiting viral replication at a post-entry stage [18]. Understanding these molecular mechanisms is crucial for developing host-directed antiviral therapies that are less prone to resistance than direct-acting antivirals.

Global Epidemiology and Phylogeographic Lineage Distribution

Since its initial identification in Hong Kong in 2012, porcine deltacoronavirus (PDCoV) has emerged as a globally significant enteric pathogen of swine, exhibiting a complex phylogeographic landscape that continues to evolve through recombination, genetic drift, and long-distance dissemination via animal movement and trade [1-3]. The virus has been documented across a rapidly expanding geographic footprint encompassing Asia, North America, and, most recently, South America, with serological and molecular evidence indicating a sustained circulation that poses considerable challenges for disease control and biosecurity at national and international levels. The World Organisation for Animal Health (WOAH) classifies PDCoV as an emerging swine disease of economic importance, and the Food and Agriculture Organization (FAO) has highlighted its potential for cross-border transmission through live animal trade and contaminated fomites, underscoring the urgency of robust epidemiological surveillance.

1.1. Historical Emergence and Initial Geographic Dissemination

The earliest documented PDCoV strains, HKU15-44 and HKU15-155, were identified through a surveillance program for coronaviruses in mammalian and avian species conducted in Hong Kong [1, 13]. Retrospective analysis subsequently identified the strain S27 in Sichuan, China, dating back to 2012, indicating that the virus had been circulating in mainland Chinese swine populations prior to its formal recognition [13]. For several years following its discovery, PDCoV was considered an Asian-endemic pathogen, with reports confined to China, South Korea, and Thailand [1, 2, 13]. The first major intercontinental jump occurred in early 2014, when PDCoV was detected in piglets with acute watery diarrhea on swine farms in Ohio, United States, followed by rapid spread across multiple states, including Iowa, Illinois, and Minnesota [16, 24]. This trans-Pacific incursion mirrored the earlier introduction of porcine epidemic diarrhea virus (PEDV) into North America in 2013, suggesting shared epidemiological pathways, likely involving contaminated feed ingredients or fomites. Retrospective testing of diagnostic samples in the United States revealed that PDCoV was present as early as August 2013, preceding the official index case by several months, implying cryptic circulation before clinical recognition [16]. The virus subsequently spread to Canada and Mexico, establishing a North American lineage that remains genetically distinct from most contemporary Asian strains [1, 11]. In 2015, PDCoV was reported in Thailand, where an outbreak on a commercial farm caused mortality rates of 27.63% in sows and 64.27% in piglets, with the Thai strains exhibiting unique deletions in the 5′-UTR and ORF1ab regions, suggesting a single introduction event followed by local adaptation [13]. Notably, the first South American detection occurred in 2019 in San Martin, Peru, where a strain with 99.5% nucleotide identity to North American reference sequences was isolated, confirming transcontinental spread beyond the established Eurasian and North American foci [11, 14]. Despite extensive surveillance, PDCoV has not yet been reported in Europe or Africa, although the continued globalization of swine production and trade networks renders incursion into these regions a credible future threat.

1.2. Phylogeographic Lineage Classification Systems

The escalating availability of complete PDCoV genome sequences has necessitated the development of robust phylogenetic classification frameworks to track evolutionary trajectories and inform epidemiological investigations. Early attempts at classification, based primarily on the spike (S) gene, delineated three major lineages: a China lineage, a USA/Japan/South Korea lineage, and a Vietnam/Laos/Thailand lineage, with the Chinese strains exhibiting the greatest genetic divergence [12]. However, as genomic data expanded, more refined schemes were proposed. Guo et al. [1] performed comprehensive phylogenetic analyses of global PDCoV genomes and established a bifurcating classification into two major lineages, lineage 1 and lineage 2, each further subdivided into sublineages. Lineage 1 encompasses sublineage 1.1 (principally Chinese strains) and sublineage 1.2 (predominantly North American strains), while lineage 2 comprises sublineage 2.1 (Southeast Asian strains from Vietnam, Laos, Thailand) and sublineage 2.2 (additional Chinese strains). This lineage demarcation is supported by genomic structural markers; lineage 2 strains consistently harbor a continuous 6-nucleotide deletion in non-structural protein 2 (Nsp2) and a 9-nucleotide deletion in Nsp3, which are absent in most lineage 1 strains [1, 7]. An alternative classification, proposed by Hsueh et al. [2], divided PDCoV strains into two major genogroups (G-I and G-II), with G-II further partitioned into three subgroups (G-II-a, G-II-b, and G-II-c). The Taiwanese strain PDCoV/104-553/TW-2015 was placed within G-II-b, a subgroup composed predominantly of Chinese variants, highlighting the genetic affinity between insular and mainland Chinese isolates [2]. More recent analyses have identified an emerging lineage, provisionally designated China 1.3, which began diverging around 2012 and is characterized by unique patterns of mutations, deletions, and insertions in the S, M, and N genes, some of which are shared with the China 1.2 lineage [3]. The China 1.3 lineage was initially identified in Guangxi Province, southern China, and its increasing prevalence underscores the ongoing evolutionary dynamism of PDCoV in its presumptive ancestral range [3].

The incongruence between genome-based and S gene-based phylogenies, combined with the high recombination frequency observed in the Nsp2, Nsp3, and S gene regions, complicates lineage assignment and suggests that recombination, rather than strict clonal evolution, is a major driver of PDCoV genetic diversity [1, 9]. For instance, the Chinese strain CHN-HeN06-2022 is a recombinant with segment exchanges between sublineage 1.1 and sublineage 2.1 across the Nsp2-Nsp3 junction, illustrating how inter-lineage recombination can generate chimeric genomes that defy simple classification [1]. Similarly, the Sichuan isolate CHN-SC2015 experienced recombination between the Chinese strains SHJS/SL/2016 and TT-1115, contributing to its distinctive ORF1ab insertion-deletion signatures [9]. These findings have profound implications for vaccine design and diagnostic assay development, as recombinant viruses may possess altered antigenic profiles and escape detection by assays targeting conserved lineage-specific markers.

1.3. Geographic Distribution of Major Lineages

The phylogeographic distribution of PDCoV lineages reveals both spatial clustering and long-range connectivity. Sublineage 1.1 (China lineage) is the most genetically diverse and widely distributed within China, having been detected in multiple provinces including Henan, Sichuan, Hubei, Guangxi, and Guangdong [1, 3, 12, 22]. Strains within this sublineage exhibit considerable variation in pathogenicity and tissue tropism; for example, the Guangxi isolate CHN/GX/1468B/2017, which groups phylogenetically with Southeast Asian strains (sublineage 2.1), caused severe diarrhea and extensive intestinal lesions in experimentally infected piglets but did not result in mortality, whereas other Chinese isolates have induced high fatality rates [7, 9]. Sublineage 1.2 (North American lineage) shows relatively low genetic diversity, consistent with a founder effect following a single or limited introduction event around 2013–2014 [1, 11]. Strains from the United States, Peru, and South Korea cluster tightly within this sublineage, indicating that the Korean strains may have been introduced from North America rather than directly from China [11, 22]. The Peruvian strain, the only South American isolate characterized to date, shares 99.5% nucleotide identity with contemporary US strains, supporting a recent North American origin [11, 14]. Sublineage 2.1 (Southeast Asian lineage) includes strains from Thailand [13], Vietnam [12], and Laos [12], as well as the aforementioned Guangxi strain CHN/GX/1468B/2017, suggesting bidirectional viral exchange between southern China and mainland Southeast Asia, likely facilitated by cross-border pig trade [7]. Sublineage 2.2 comprises a distinct cluster of Chinese strains that share the characteristic ORF1a deletions with Southeast Asian isolates but form a monophyletic group separate from sublineage 2.1, indicating an independent evolutionary trajectory within China [1].

1.4. Cross-Species Transmission and the Avian Deltacoronavirus Reservoir

A critical dimension of PDCoV epidemiology is its association with deltacoronaviruses circulating in avian species. Phylogenetic analyses consistently demonstrate that PDCoV is most closely related to sparrow deltacoronavirus (SpDCoV) HKU17, suggesting that the progenitor of PDCoV may have originated in birds and undergone a host-switching event into swine [8, 15]. The isolation of pigeon deltacoronaviruses (PiDCoV) from live poultry markets in Shandong Province, China, which share 95.6–96.2% nucleotide identity with SpDCoV HKU17 and cluster alongside PDCoV, further supports the hypothesis that avian species serve as a reservoir from which porcine deltacoronaviruses periodically emerge [8]. Moreover, a deltacoronavirus identified in black-headed gulls (Chroicocephalus ridibundus) in Yunnan Province, China, exhibited high amino acid sequence similarity in NSP12 to falcon coronavirus UAE-HKU27, houbara coronavirus UAE-HKU28, and pigeon coronavirus UAE-HKU29, indicating frequent interspecies transmission events within the avian Deltacoronavirus genus and across different avian orders [15]. Coevolutionary analyses have predicted host-switching from houbara to falcon, pigeon, and white-eye; from sparrow to common magpie and quail; and crucially, from sparrow to swine and even Asian leopard cats, highlighting the zoonotic and cross-species spillover potential of this viral genus [15]. The discovery of PDCoV RNA in plasma samples from children in Haiti in 2021, who presented with acute febrile illness, provides direct evidence that PDCoV can infect humans, elevating its public health significance and underscoring the need for enhanced surveillance at the human-animal interface [8].

1.5. Epidemiological Drivers of Global Spread

Several ecological and anthropogenic factors have facilitated the rapid global dissemination of PDCoV. The high viral load shed in diarrheic feces, often exceeding 10⁸ TCID₅₀/mL, coupled with environmental stability in organic matter, enables efficient fecal-oral transmission within and between farms [7, 13]. The virus has been detected in feed, transport vehicles, and on surfaces in swine facilities, supporting a role for fomites in long-distance spread [16]. In North America, the initial outbreak was associated with contaminated feed ingredients of Asian origin, a pathway previously implicated in PEDV introduction [16]. In China, the co-circulation of multiple PDCoV lineages and the high prevalence of co-infections with PEDV, up to 55.95% in some surveys, create opportunities for recombination and potentially increased virulence through synergistic pathogenesis [12, 22]. Seasonal patterns have also been observed, with the highest percentage of PDCoV-positive submissions in North America occurring during December through February, likely due to cold temperatures that enhance viral survival in the environment and increased animal density during winter housing [24]. The emergence of recombinant strains, such as CHN-HeN06-2022, which arose through segment exchange between sublineage 1.1 and sublineage 2.1, highlights the ongoing risk of novel variant emergence in regions where multiple lineages co-circulate, particularly in high-density pig production areas of southern China [1].

1.6. Implications for Surveillance and Control

The phylogeographic complexity of PDCoV has direct implications for diagnostic assay design and vaccine development. The S gene, which encodes the major neutralizing epitopes, is under strong positive selection, with 14 amino acid sites under positive selection identified in the spike protein, predominantly located in regions involved in viral attachment, receptor binding, and membrane fusion [1]. This antigenic variability necessitates continuous monitoring to ensure that diagnostic assays, such as the quantitative PCR methods and immunochromatographic strips developed for field use, remain capable of detecting emergent lineages [4, 5, 20, 21]. The development of a multiplex quantitative PCR capable of simultaneous detection of PEDV, transmissible gastroenteritis virus, and PDCoV has proven valuable for the differential diagnosis of swine enteric coronaviruses, particularly given the high rates of co-infection [19]. Similarly, the implementation of next-generation sequencing-based surveillance platforms, such as the United States Swine Pathogen Database, facilitates real-time tracking of lineage distribution and the early detection of recombinants or novel variants [23]. The data standardization initiatives that enable inter-laboratory data sharing across veterinary diagnostic laboratories are essential for monitoring the seasonal and geographic patterns of PDCoV detection and for providing early warning of incursions into naive populations [24]. Given the documented zoonotic potential and the repeated evidence of cross-species transmission from avian reservoirs, a One Health approach integrating surveillance in swine, avian, and human populations is imperative for mitigating the risks posed by this increasingly ubiquitous enteric coronavirus.

Genetic Diversity, Recombination, and Adaptive Evolution

Since its initial identification in Hong Kong in 2012, porcine deltacoronavirus (PDCoV) has emerged as a globally significant enteric pathogen of swine, with a demonstrated capacity for rapid genetic diversification, inter-lineage recombination, and adaptive evolution that facilitates cross-species transmission. The evolutionary dynamics of PDCoV reflect a complex interplay between a highly error-prone RNA-dependent RNA polymerase (RdRp), extensive genome plasticity, and selective pressures exerted by host immune responses and ecological niche expansion. A thorough understanding of the mechanisms driving PDCoV genetic diversity is foundational to vaccine design, diagnostic algorithm development, and pandemic preparedness surveillance, particularly given its documented zoonotic potential in human populations, as recognized by the World Health Organization (WHO) and the Centers for Disease Control and Prevention (CDC).

Phylogenetic Classification and Lineage Structure

Comprehensive phylogenetic analyses of globally circulating PDCoV strains have consistently resolved two major lineages, which have been further subdivided into distinct sublineages corresponding to geographic and temporal patterns of emergence. Guo et al. [1] employed whole-genome phylogeny to delineate lineage 1 and lineage 2, with sublineage 1.1 encompassing Chinese strains, sublineage 1.2 representing North American strains, sublineage 2.1 comprising Southeast Asian strains, and sublineage 2.2 containing a distinct cluster of Chinese strains. This two-lineage framework was corroborated and refined by Hsueh et al. [2], who proposed a classification into genogroup I (G-I) and genogroup II (G-II), with G-II further subdivided into G-II-a, G-II-b, and G-II-c subgroups. Importantly, the Taiwanese isolate PDCoV/104-553/TW-2015 was assigned to the G-II-b group, which predominantly consists of Chinese variant strains, suggesting a common ancestry and ongoing transboundary viral flux across the Taiwan Strait [2]. The utility of this phylogenetic framework extends beyond taxonomy; it provides a predictive scaffold for understanding differential pathogenicity and the geographical dissemination of emergent variants.

More recent surveillance in southern China has revealed ongoing lineage diversification, with Li et al. [3] identifying a novel China 1.3 lineage that began diverging as early as 2012, as estimated by Bayesian coalescent analysis. Bayesian molecular clock modeling placed the time of most recent common ancestor (tMRCA) for this lineage in the early 2010s, coinciding temporally with the initial description of PDCoV in Hong Kong and suggesting that cryptic circulation and diversification predated the recognized outbreaks in North America [3]. The genetic distance between China 1.3 and other Chinese lineages (China 1.1 and China 1.2) is considerable, with amino acid substitutions, deletions, and insertions concentrated in the spike (S) glycoprotein and non-structural protein (nsp) coding regions, indicating that this lineage may possess distinct antigenic and perhaps pathogenic properties [3].

Genetic Signatures: Insertions and Deletions as Phylogenetic Markers

A hallmark of PDCoV genetic diversity is the presence of characteristic insertion-deletion (indel) signatures that serve as robust phylogenetic markers. Guo et al. [1] systematically demonstrated that lineage 2 strains uniformly harbor a continuous 6-nucleotide (nt) deletion in nsp2 and a 9-nt deletion in nsp3 relative to lineage 1 strains. These indels are not randomly distributed but are evolutionarily conserved within specific lineages, indicating that they may confer a selective advantage or at minimum are not deleterious. Wang et al. [7] confirmed the presence of these deletions in the ORF1a gene of the Southeast Asia-like strain CHN/GX/1468B/2017, with precise deletions at positions 1,733–1,738 (6 nt) and 2,804–2,812 (9 nt). Similarly, the Sichuan isolate CHN-SC2015 was reported by Zhao et al. [9] to contain both a 6-nt deletion and a 9-nt insertion in ORF1ab, along with a 3-nt deletion in the S gene and a distinctive 11-nt deletion in the 3′ untranslated region (UTR). Feng et al. [22] further substantiated these patterns across four Sichuan PDCoV strains, identifying the 6-nt deletion in nsp2, the 9-nt insertion in nsp3, the 3-nt deletion in S, and the 11-nt deletion in 3′ UTR as consistent features distinguishing Chinese strains from their American counterparts.

Beyond their utility as phylogenetic markers, these indels may have functional consequences. The deletions in nsp2 and nsp3 occur within the replicase polyprotein, and although the precise impact on protease activity or membrane rearrangement remains to be fully elucidated, structural modeling suggests that these deletions could alter protein conformation and potentially modulate viral replication kinetics. The 3-nt deletion in the S gene, first described in CHN-SC2015 [9] and subsequently observed by Feng et al. [22], maps to a region proximal to the S1/S2 cleavage site, which is critical for host cell entry and tropism. The 11-nt deletion in the 3′ UTR is of particular interest given that the 3′ UTR of coronaviruses contains cis-acting RNA elements essential for subgenomic mRNA synthesis and genome replication; deletion of these elements could impact viral fitness in a cell-type-specific manner.

Recombination as a Driver of Genetic Diversity

Recombination is a major evolutionary force shaping PDCoV genetic diversity, as has been extensively documented for other coronaviruses. The high frequency of homologous recombination in PDCoV is attributable to the discontinuous nature of coronavirus RNA synthesis, during which the RdRp can template-switch between co-infecting viral genomes. Guo et al. [1] provided compelling evidence for recombination by characterizing the novel strain CHN-HeN06-2022, which arose from a segment exchange event crossing the nsp2 and nsp3 regions between a sublineage 1.1 strain and a sublineage 2.1 strain. This recombinant displayed 98.3–98.7% nucleotide identity with Chinese and American reference strains, yet its mosaic genome architecture clearly indicated a chimeric origin [1]. Critically, Guo et al. [1] identified that the highest recombination frequency across all documented PDCoV strains occurs in the nsp2, nsp3, and S gene regions, implicating these genomic hotspots as preferred sites for template-switching events.

Li et al. [3] described interlineage recombination in Guangxi province strains CHGX-MT505459-2019 and CHGX-MT505449-2017, further emphasizing that recombination is not a rare event but a persistent mechanism generating novel genotypes. These recombination events were detected using a combination of phylogenetic incongruence testing, similarity plot analysis, and bootscanning methods, which together provide robust statistical support for the identification of breakpoints. Zhao et al. [9] reported that CHN-SC2015 resulted from recombination between the Chinese strain SHJS/SL/2016 and the prototype strain TT-1115, illustrating that recombination can occur between geographically and temporally distinct strains, thereby generating hybrid viruses with potentially novel properties. Hsueh et al. [2] proposed that the numerous mutations observed in the Taiwanese PDCoV strain 104-553/TW-2015 might be linked to recombination with other PDCoV genogroups or even with other porcine coronaviruses, broadening the potential donor pool for genetic exchange.

The S gene is a particularly frequent target of recombination due to its location at the 3′ end of the genome, where the RNA-dependent RNA polymerase is more prone to dissociation and re-association. Recombination in the S gene can lead to the exchange of entire receptor-binding domains or the S1/S2 cleavage site, with profound implications for host range and antigenicity. Li et al. [25] documented a recombination event in the S2 gene of the PEDV strain CH/hubei/2016 between parental strains AH2012-12 (G2b) and CH-ZMDZY-11 (G2a), and though this study focused on PEDV, the mechanistic parallels to PDCoV recombination are instructive. The high recombination frequency at the S gene in PDCoV [1] suggests that porcine deltacoronavirus is similarly capable of shuffling antigenic determinants, potentially allowing it to evade pre-existing immunity in swine populations.

Positive Selection and Adaptive Evolution in the Spike Protein

The spike (S) glycoprotein is the primary target of host neutralizing antibodies and the principal determinant of cellular tropism, making it the focus of intense selective pressure. Guo et al. [1] identified a total of 14 amino acid sites under positive selection in the PDCoV S protein, with the majority localized to the S1 subunit, which mediates receptor binding, and the fusion peptide region of S2. Positive selection was detected using multiple codon-based maximum likelihood methods (including single-likelihood ancestor counting, fixed-effects likelihood, and mixed-effects model of evolution), providing robust evidence that these sites are evolving under diversifying selection rather than neutral drift. The spatial distribution of these positively selected sites maps to the predicted receptor-binding domain (RBD) and the S1/S2 cleavage junction, two regions critical for host cell entry. Mutations in these domains could alter the affinity of the S protein for its receptor (aminopeptidase N, APN) or the proteolytic processing required for membrane fusion, thereby modulating both infectivity and tissue tropism.

The adaptive evolution of the PDCoV S gene is not limited to point mutations. Zhang et al. [12] reported a novel monophyletic branch of Chinese PDCoVs that exhibited a possible recombination event between positions 27 and 1234 of the S gene, suggesting that selection acts on both newly introduced variants derived from recombination and de novo mutations. Significant amino acid substitutions in the S protein were visualized on a three-dimensional structural model, revealing that many of these changes are surface-exposed and thus likely to be accessible to antibodies [12]. This structural context is crucial for understanding how PDCoV may evade herd immunity and for rational design of S-based vaccine antigens.

In contrast to the diversifying selection observed in the S gene, other genomic regions appear to be under purifying selection, reflecting functional constraints. Li et al. [25] demonstrated 10 purifying selection sites in the PEDV S gene, and although their study focused on PEDV, the pattern likely extends to PDCoV, where structural and enzymatic proteins such as the RdRp and the nucleocapsid (N) protein are subject to strong functional constraints that limit amino acid variation. The N protein, while immunogenic and used as the basis for several diagnostic ELISAs [4, 6], is relatively conserved compared to S, consistent with its essential role in RNA binding and genome packaging.

Cross-Species Transmission and the Role of Avian Deltacoronaviruses

The genetic diversity of PDCoV is inextricably linked to its capacity for cross-species transmission. Phylogenetic analyses have consistently demonstrated that PDCoV is most closely related to sparrow deltacoronavirus (SpDCoV) HKU17, suggesting an avian origin for the porcine virus [8]. The genomic organization of these avian deltacoronaviruses, including the characteristic gene order of 5′-replicase-S-E-M-N-3′ and the presence of accessory genes, is highly similar to that of PDCoV, supporting a common ancestral lineage [8]. Wang et al. [8] identified two pigeon deltacoronaviruses (PiDCoV) in a live poultry market in Shandong Province, China, that clustered phylogenetically with SpDCoV HKU17 and PDCoV, with nucleotide identities of 95.6–96.2% in the partial RdRp gene. The detection of these viruses in multiple avian species (sparrows, pigeons, and quail) indicates that deltacoronaviruses circulate broadly in wild and domestic birds, creating a reservoir from which spillover into swine can occur.

The interspecies transmission potential of deltacoronaviruses is further underscored by Chu et al. [15], who characterized three strains of DCoV (HNU4-1, HNU4-2, and HNU4-3) from black-headed gulls (Chroicocephalus ridibundus) in Yunnan Province, China. Their coevolutionary analysis predicted multiple host-switching events: from houbara to falcon, pigeon, and white-eye; from sparrow to common magpie, quail, and mammals (including swine and Asian leopard cat); and from munia to magpie-robin [15]. These data suggest that deltacoronaviruses have undergone frequent and relatively recent cross-species transmission events, with avian species serving as the primary reservoir and swine as a secondary, or spillover, host. The detection of PDCoV in children with acute febrile illness in Haiti, reported by the CDC, confirms that this virus possesses the ability to infect humans, raising important questions about the genetic determinants of host range expansion.

The molecular underpinnings of cross-species transmission likely involve adaptation of the S protein to utilize species-specific APN orthologs. The positively selected sites identified in the PDCoV RBD [1] may represent residues that are under selective pressure to accommodate APN from different species. Moreover, the recombination events documented in the S gene could facilitate the exchange of entire RBD modules between different deltacoronavirus lineages, allowing a porcine-adapted

Diagnostics: Molecular Detection and Serological Assays

The accurate and timely diagnosis of porcine deltacoronavirus (PDCoV) is paramount for effective disease surveillance, outbreak management, and the implementation of control strategies within the global swine industry. Given the clinical similarity of PDCoV-induced diarrhea to that caused by other major swine enteric coronaviruses (SECoVs), namely porcine epidemic diarrhea virus (PEDV), transmissible gastroenteritis virus (TGEV), and swine acute diarrhea syndrome coronavirus (SADS-CoV), definitive diagnosis cannot be achieved through clinical observation alone [17, 19, 21]. Consequently, a robust armamentarium of molecular and serological diagnostic tools has been developed, each with distinct advantages and limitations regarding sensitivity, specificity, throughput, cost, and applicability in field versus laboratory settings. The diagnostic landscape for PDCoV has evolved rapidly, moving from conventional reverse transcription PCR (RT-PCR) to sophisticated multiplex quantitative platforms, isothermal amplification methods, and high-throughput serological assays, all of which are critical for understanding the virus's epidemiology, evolution, and zoonotic potential, a concern highlighted by the detection of PDCoV in human plasma samples in Haiti [8].

Molecular Detection: Nucleic Acid-Based Assays

Molecular diagnostics, primarily based on the detection of viral RNA, represent the gold standard for the acute-phase diagnosis of PDCoV infection. These assays offer unparalleled sensitivity and specificity, enabling the detection of the virus even in subclinical cases or during the early stages of infection when viral shedding is low. The choice of target gene is critical; conserved regions within the nucleocapsid (N), membrane (M), spike (S), and ORF1b genes are frequently selected to ensure broad detection across diverse PDCoV lineages [19, 20].

Quantitative Real-Time RT-PCR (RT-qPCR) and Multiplex Platforms

Singleplex and multiplex quantitative real-time RT-PCR (RT-qPCR) assays are the workhorses of veterinary diagnostic laboratories (VDLs) worldwide. The high sensitivity of these assays, often achieving limits of detection (LOD) as low as 10 copies/μL, allows for the quantification of viral RNA in clinical specimens such as feces, rectal swabs, and intestinal contents [19]. This quantification is not merely academic; the cycle threshold (Ct) value provides a semi-quantitative measure of viral load, which correlates with the severity of clinical disease and the stage of infection. For instance, Ct values between 9 and 14 have been reported in acutely infected piglets with severe diarrhea, indicating extremely high viral loads [11, 14].

The necessity for differential diagnosis has driven the development of multiplex RT-qPCR assays capable of simultaneously detecting and differentiating PDCoV from other SECoVs. A landmark study by Chen et al. [19] developed a triplex qPCR targeting the PDCoV N gene, the PEDV M gene, and the TGEV S gene, incorporating a porcine β-Actin internal control. This assay demonstrated exceptional analytical performance with an LOD of 10 copies/μL and no cross-reactivity with other common porcine viruses. When applied to 462 clinical samples from five Chinese provinces, it revealed a PDCoV discrete positive rate of 10.17% and, critically, a high rate of co-infection, with 23.16% of samples testing positive for both PEDV and PDCoV [19]. This finding underscores the biological reality of concurrent infections on farms and the absolute necessity for multiplex diagnostic approaches. The ability to detect and differentiate these pathogens in a single reaction not only saves time and resources but also provides a more comprehensive picture of the enteric disease complex, which is essential for implementing targeted intervention strategies. The World Organisation for Animal Health (WOAH) recognizes the importance of such validated molecular assays for the surveillance of notifiable and emerging diseases.

Isothermal Amplification Technologies: RT-RAA and RT-LAMP

While RT-qPCR remains the reference standard, its reliance on expensive thermal cyclers and skilled personnel limits its deployment in resource-limited settings or for on-farm point-of-care (POC) testing. Isothermal amplification technologies, such as reverse transcription recombinase-aided amplification (RT-RAA) and reverse transcription loop-mediated isothermal amplification (RT-LAMP), have emerged as powerful alternatives that address these logistical constraints.

The RT-RAA assay, when coupled with a lateral flow dipstick (LFD), represents a paradigm shift in rapid PDCoV detection. Zeng et al. [20] developed an RT-RAA-LFD assay targeting a highly conserved region of the ORF1b gene. The entire process, from sample to result, can be completed in approximately 11 minutes, a stark contrast to the 1-2 hours required for RT-qPCR. The amplification occurs at a constant 40°C, eliminating the need for a thermal cycler, and the result is visualized on an LFD, which is as simple to interpret as a pregnancy test. The assay demonstrated a 95% LOD of 3.97 TCID50 per reaction, comparable to a reference TaqMan-based real-time RT-PCR, and showed 97.32% diagnostic concordance with the reference method when testing 149 clinical samples [20]. This technology is ideally suited for rapid screening during outbreak investigations at the farm level.

Similarly, RT-LAMP offers a rapid and robust alternative. A portable, 3D-printed microfluidic device incorporating RT-LAMP was developed for the multiplex detection of PEDV, TGEV, and PDCoV [21]. This "lab-on-a-chip" device automates sample distribution and self-sealing, delivering results within 30 minutes. The analytical performance was comparable to benchtop RT-LAMP and qRT-PCR, with LODs of 10 genomic copies per reaction for PDCoV [21]. The integration of microfluidics with isothermal amplification represents a significant step towards fully automated, field-deployable diagnostic systems that can be used by farm personnel with minimal training. These technologies align with the WOAH's goals for improving disease surveillance in low-resource environments.

Next-Generation Sequencing (NGS) and Metagenomics

For comprehensive virological characterization, outbreak investigations, and the discovery of novel or recombinant strains, next-generation sequencing (NGS) is an indispensable tool. NGS provides the full-length genome sequence of the virus, enabling detailed phylogenetic analyses, the identification of recombination events, and the tracking of viral evolution and transmission pathways [1, 7, 30]. The protocol developed by Kubacki et al. [30] for use in VDLs demonstrated the successful application of NGS for virus identification, characterization, and herd screening directly from clinical samples.

The value of NGS is particularly evident in the context of PDCoV's high genetic diversity and propensity for recombination. Genomic analysis of a novel recombinant strain, CHN-HeN06-2022, revealed that it emerged from segment exchange between sublineage 1.1 and sublineage 2.1 in the Nsp2 and Nsp3 regions [1]. Similarly, NGS was instrumental in identifying the first PDCoV strain in South America (Peru), which was found to be 99.5% identical to a North American strain, providing critical insights into the virus's global spread [11, 14]. Furthermore, metagenomic NGS is crucial for detecting co-infections and identifying other potential enteric pathogens, such as porcine sapelovirus (PSV) or porcine rotavirus B, which can complicate the clinical picture [27, 29]. The integration of NGS data into centralized databases, such as the United States Swine Pathogen Database, is vital for real-time genomic surveillance and pandemic preparedness [23].

Advanced Molecular Platforms: MALDI-TOF NAMS

A novel and highly promising addition to the molecular diagnostic toolkit is the use of Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Nucleic Acid Mass Spectrometry (MALDI-TOF NAMS). This technology combines multiplex PCR with mass spectrometry to detect and differentiate multiple pathogens simultaneously. A recent study developed a MALDI-TOF NAMS assay for the simultaneous detection of eight major porcine gastrointestinal pathogens, including PDCoV [28]. The assay demonstrated high analytical specificity with no cross-reactivity, an LOD ranging from 12.20 to 33.59 copies/μL, and 100% reproducibility. When validated against 242 clinical samples, it showed 98.3% sensitivity and 99.5% specificity compared to qPCR [28]. The high-throughput nature of MALDI-TOF NAMS, capable of analyzing hundreds of samples per day, makes it an exceptionally powerful tool for large-scale epidemiological surveillance and for unraveling the complex polymicrobial etiology of swine diarrhea.

Serological Assays: Detecting the Host Response

While molecular assays detect the virus itself, serological assays detect the host's adaptive immune response, primarily antibodies (Abs) against PDCoV. Serology is essential for determining prior exposure, monitoring herd immunity, evaluating vaccine efficacy, and conducting large-scale seroprevalence studies. The primary target antigen for serological assays is the nucleocapsid (N) protein, which is highly immunogenic and abundantly expressed during infection [4, 6, 10].

Competitive and Blocking ELISA

Enzyme-linked immunosorbent assays (ELISAs) are the most common serological platform due to their high throughput, objectivity, and relatively low cost. Two major formats have been developed for PDCoV: competitive ELISA (cELISA) and blocking ELISA (bELISA). Both formats utilize a monoclonal antibody (mAb) specific to the PDCoV N protein, which competes with antibodies in the test serum for binding to the coated antigen. This design confers high specificity, as the mAb recognizes a single, defined epitope.

Wang et al. [4] developed a cELISA using a purified recombinant PDCoV N protein as the coating antigen and a specific mAb as the detection probe. Using receiver operating characteristic (ROC) curve analysis against a reference indirect immunofluorescence assay (IFA), the optimal cutoff was determined to be 26.8% inhibition (PI), yielding a diagnostic sensitivity of 97.44% and specificity of 96.34%. The assay showed excellent agreement with the virus neutralization test (VNT), with a coincidence rate of 92.7% and a κ value of 0.851, indicating "almost perfect agreement" [4]. This cELISA is a robust tool for assessing herd immunity and vaccine responses.

In a separate study, Wang et al. [6] developed a blocking ELISA (bELISA) using a similar N protein-based approach. This assay demonstrated even higher performance, with a diagnostic sensitivity of 98.79% and a specificity of 100% at a cutoff of 51.65% PI, as determined by ROC analysis and Youden’s index. The overall coincidence rate with IFA was 98.96% [6]. The high specificity of these assays is critical to avoid false positives, which could lead to unnecessary culling or movement restrictions. The development of these validated ELISAs provides VDLs with standardized, reliable methods for PDCoV serosurveillance, a key component of national control programs as recommended by the WOAH.

Immunochromatographic Strips (Lateral Flow Assays)

For rapid, on-site serological screening, immunochromatographic strip (ICS) assays, or lateral flow assays, offer a compelling solution. While many ICS detect viral antigen, a quantum dot-based ICS (QD-ICS) was developed for the detection of the PDCoV N protein, functioning as an antigen-capture test rather than a serological antibody test [5]. This distinction is critical. The QD-ICS uses a double-antibody sandwich format, employing a QD-conjugated mouse anti-PDCoV-N mAb as the detection probe and a rabbit anti-PDCoV-N polyclonal antibody as the capture antibody. The assay achieved a 95% LOD of 236.661 TCID50/mL, exhibited no cross-reactivity with other major swine pathogens, and showed 96.7% concordance with reference real-time RT-PCR when testing 60 clinical rectal swabs [5]. The entire test can be completed in minutes without specialized equipment, making it an ideal "pen-side" diagnostic tool for rapid confirmation of clinical cases. This technology is particularly valuable for veterinarians making immediate treatment and biosecurity decisions.

Virus Neutralization Test (VNT)

The virus neutralization test (VNT) remains the gold standard for serological diagnosis, as it specifically detects neutralizing antibodies (nAbs) that are correlated with protective immunity. The VNT measures the functional ability of serum antibodies to inhibit viral infection in cell culture. Zhao et al. [26] demonstrated that PDCoV infection in conventionally weaned pigs induces high titers of virus-neutralizing antibodies, which correlate with protection against rechallenge. While the VNT is highly specific and biologically relevant, it is labor-intensive, time-consuming (requiring 2-3 days), and requires live virus and cell culture facilities, limiting its use to specialized reference laboratories. The high concordance between the developed cELISA and the VNT suggests that the cELISA can serve as a reliable surrogate for the more complex VNT in routine surveillance [4].

Conclusion of Diagnostic Section

The diagnostic toolkit for PDCoV is both diverse and sophisticated, reflecting the virus's significant economic impact and zoonotic concern. Molecular methods, from high-throughput multiplex qPCR and NGS to rapid isothermal assays like RT-RAA-LFD, provide the sensitivity and specificity needed for acute diagnosis and genetic characterization. Serological assays, particularly the newly developed cELISA and bELISA, offer the high-throughput, standardized platforms required for large-scale surveillance and vaccine evaluation. The continued development and validation of these assays, in alignment with international standards, are essential for a coordinated global response to this emerging pathogenchers. The integration of these tools into a cohesive diagnostic algorithm will empower veterinarians and producers to make data-driven decisions, ultimately mitigating the impact of PDCoV on swine health and production.

Host Range, Cross-Species Transmission, and Zoonotic Potential

Domestic Swine as the Primary Reservoir

Porcine deltacoronavirus (PDCoV) was first identified in Hong Kong in 2012 [1, 8], and since its initial characterization, domestic swine (Sus scrofa domesticus) have been recognized as the primary and most epidemiologically significant reservoir host. The virus exhibits a pronounced tropism for the porcine intestinal tract, causing acute, often severe, watery diarrhea, vomiting, dehydration, and mortality, particularly in neonatal piglets [7, 9, 13]. Experimental oral inoculation of 7-day-old piglets with the Southeast Asia-like strain CHN/GX/1468B/2017 resulted in profuse diarrhea with peak viral shedding at 4 days post-infection, alongside a significantly reduced villus height-to-crypt depth ratio in the jejunum and ileum, confirming the profound enteropathogenicity of PDCoV in its natural host [7]. Similarly, the CHN-SC2015 isolate from southwest China induced diarrhea, vomiting, dehydration, and death in suckling piglets, with virus widely disseminated throughout the gastrointestinal tract and multiple extra-intestinal organs [9]. The morbidity and mortality rates in swine operations are substantial; a 2015 outbreak on a commercial farm in Thailand reported a mortality rate of 27.63% in sows and 64.27% in piglets, with a total piglet death loss of 19.22% over ten production weeks [13]. These stark figures underscore the severe economic and animal welfare burden PDCoV imposes on the global swine industry, with the World Organisation for Animal Health (WOAH) recognizing PDCoV as an important emerging swine enteric coronavirus requiring vigilant international surveillance.

Expanding Host Range in Domestic and Wild Animals

Beyond its established pathogenicity in pigs, PDCoV has demonstrated a remarkable capacity to infect a broad and phylogenetically diverse range of vertebrate hosts, including calves, chickens, turkey poults, and even humans [1]. This expanding host range is a defining characteristic that elevates PDCoV from a strictly porcine pathogen to a virus of considerable One Health concern. Serological surveys and molecular detection have provided compelling evidence of PDCoV infection in cattle, with antibodies and viral RNA detected in bovine populations in China, suggesting that cattle may serve as a clinically silent or mildly symptomatic reservoir [1]. The detection of PDCoV in domestic poultry, including chickens and turkeys, is particularly alarming, given the enormous scale of global poultry production and the potential for the virus to establish an avian reservoir that could facilitate sustained circulation and further genetic diversification [1]. Experimental infections in turkey poults have confirmed that PDCoV can replicate and cause intestinal lesions, albeit with variable clinical outcomes, highlighting the susceptibility of galliform birds [1].

The discovery of deltacoronaviruses in avian species with close phylogenetic relationships to PDCoV provides critical evolutionary context for understanding the virus's cross-species transmission potential. In a live poultry market in Shandong Province, China, two pigeon deltacoronaviruses (PiDCoV) were identified that are genetically closely related to PDCoV HKU15 and sparrow deltacoronavirus HKU17 [8]. Genome sequencing revealed that the PiDCoV strain WS38 possesses a genome organization characteristic of the Deltacoronavirus genus and clusters phylogenetically with known PDCoV and sparrow DCoV strains [8]. This finding is not an isolated event; a comprehensive study of deltacoronaviruses in black-headed gulls (Chroicocephalus ridibundus) in South China identified three novel DCoV strains (HNU4-1, HNU4-2, HNU4-3) that share >99% genomic identity with each other and exhibit high amino acid similarity in the NSP12 region to falcon coronavirus UAE-HKU27 and houbara coronavirus UAE-HKU28 [15]. Sophisticated coevolutionary and host-switching analyses predicted frequent interspecies transmission events among diverse avian orders, including from houbara to falcon, pigeon, and white-eye, and, critically, from sparrow to mammal hosts, including swine and the Asian leopard cat [15]. These data collectively paint a picture of a dynamic and actively transmitting deltacoronavirus network across avian species, with swine serving as a junction host for spillover events from birds.

Molecular Determinants of Cross-Species Tropism

The molecular basis for PDCoV's broad host range is intimately linked to the structure and function of its spike (S) glycoprotein, the primary viral determinant for receptor binding and membrane fusion. Unlike the alphacoronavirus and betacoronavirus genera, which utilize a variety of proteinaceous receptors such as aminopeptidase N (APN) or angiotensin-converting enzyme 2 (ACE2), deltacoronaviruses, including PDCoV, appear to utilize APN from multiple species as a key entry receptor. Critically, PDCoV has been demonstrated to use APN from swine, human, feline, canine, and chicken origins, a promiscuity in receptor usage that is a principal driver of its zoonotic and cross-species transmission capability. This contrasts sharply with other swine enteric coronaviruses such as PEDV and TGEV, which have a more restricted host range.

Detailed phylogenetic and evolutionary analyses of global PDCoV strains have identified a total of 14 amino acid sites under strong positive selection in the spike protein, with the majority of these sites located in functionally critical domains responsible for viral attachment, receptor binding, and membrane fusion [1]. The concentration of adaptive evolution in these regions strongly suggests that the virus is under constant selective pressure to adapt to new host environments. Recombination events, particularly those involving the S gene, are a major mechanism driving this diversification. The highest recombination frequency among PDCoV genomes occurs within the Nsp2, Nsp3, and S gene regions [1]. For instance, the Chinese recombinant strain CHN-HeN06-2022 resulted from segment exchange between sublineage 1.1 and sublineage 2.1 spanning the Nsp2 and Nsp3 region, while other strains show recombination breakpoints within the S gene itself, leading to chimeric spike proteins with altered antigenic and receptor-binding properties [1, 9]. This ongoing recombination, especially in the S gene, facilitates the generation of novel variants that may have expanded or altered host tropism, potentially allowing PDCoV to overcome species-specific barriers to infection.

Documented Zoonotic Potential and Human Infection

The most consequential evidence for PDCoV's zoonotic potential came with the detection of PDCoV infection in three children with acute febrile illness in Haiti in 2021 [8]. This landmark finding marked the first documented human infection with a deltacoronavirus and shattered the long-held paradigm that human coronavirus infections were restricted to the Alphacoronavirus and Betacoronavirus genera [8]. The children presented with fever and gastrointestinal symptoms, and subsequent molecular and phylogenetic analyses confirmed the presence of PDCoV RNA in their clinical samples, with the viral sequences clustering closely with known porcine PDCoV strains [8]. This human spillover event was not an isolated laboratory curiosity but a real-world demonstration of the virus's capacity to jump the species barrier into humans.

The seroprevalence of PDCoV antibodies in human populations is an area of active investigation. The development of high-specificity serological tools, such as the nucleocapsid protein-based blocking ELISA, has enabled large-scale serosurveillance efforts [4, 6]. These assays, which demonstrate a diagnostic sensitivity of 98.79% and specificity of 100% when tested against swine sera, are being adapted for human use to determine the true extent of PDCoV exposure in human populations, particularly in individuals with occupational exposure to swine such as farmers, veterinarians, and abattoir workers [6]. The potential for undetected or asymptomatic human infections is a significant public health concern, as it could allow for sustained cryptic transmission before a more virulent or transmissible variant emerges. Given that PDCoV can replicate efficiently in human intestinal cell lines in vitro and can use human APN as a receptor, the biological prerequisites for a human-adapted PDCoV strain are already in place. The Centers for Disease Control and Prevention (CDC) and the World Health Organization (WHO) have both highlighted the emergence of PDCoV in humans as a critical sentinel event, underscoring the need for enhanced global surveillance of animal coronaviruses with pandemic potential.

Implications for Global Health and Biosecurity

The broad host range of PDCoV, encompassing swine, cattle, poultry, multiple avian species, and now humans, fundamentally alters the epidemiological landscape of this pathogen. The presence of PDCoV in live poultry markets, as demonstrated in Shandong, China, creates a high-risk interface where multiple avian species, pigs, and humans converge, providing an ideal environment for viral mixing, recombination, and spillover [8]. The identification of deltacoronaviruses in migratory birds such as black-headed gulls further expands the potential for long-distance dissemination of the virus across continents, bypassing traditional animal movement controls [15]. This sylvatic-urban interface, where wild birds interact with domestic livestock and human populations, represents a poorly controlled conduit for viral emergence.

The economic and public health implications are profound. For the swine industry, the co-circulation of PDCoV with other enteric pathogens such as PEDV and TGEV is common, with mixed infection rates reaching as high as 23.16% for PEDV/PDCoV in Chinese swine herds [19]. These co-infections can exacerbate disease severity and complicate diagnosis and control. From a zoonotic perspective, the documented human infections in Haiti serve as a stark warning. The World Organisation for Animal Health (WOAH) recommends that PDCoV be included in routine surveillance programs for swine and that One Health surveillance frameworks be implemented to monitor PDCoV in swine, poultry, and at-risk human populations. The development of rapid, field-deployable diagnostic tests, such as the quantum dot-based immunochromatographic strip and the RT-RAA-LFD assay, is crucial for enabling real-time detection in both veterinary and public health settings [5, 20]. The potential for PDCoV to evolve into a human-adapted pathogen that transmits efficiently from person to person remains the most serious concern, necessitating a proactive, globally coordinated research and surveillance agenda.

Immune Response, Vaccine Development, and Antiviral Strategies

The interplay between porcine deltacoronavirus (PDCoV) and the host immune system is a complex and dynamic battlefield that dictates the outcome of infection, ranging from severe enteric disease to complete viral clearance and protection. Understanding these immunological mechanisms is not merely an academic exercise; it is the cornerstone upon which rational vaccine design and effective antiviral strategies are built. Given PDCoV’s status as an emerging enteropathogen with documented zoonotic potential, as highlighted by the World Health Organization (WHO) and the World Organisation for Animal Health (WOAH), the development of robust countermeasures is a critical priority for both veterinary and public health. This section provides an exhaustive analysis of the host immune response to PDCoV, the current landscape of vaccine development, and the promising avenues of antiviral intervention.

Innate and Adaptive Immune Responses to PDCoV Infection

The initial host defense against PDCoV is orchestrated by the innate immune system, a non-specific but rapid response that sets the stage for subsequent adaptive immunity. Upon infection of intestinal epithelial cells, pattern recognition receptors (PRRs) detect viral pathogen-associated molecular patterns (PAMPs), such as double-stranded RNA, triggering a signaling cascade that leads to the production of type I and type III interferons (IFNs) and pro-inflammatory cytokines. Transcriptomic analyses of infected LLC-PK cells have revealed a significant upregulation of interferon-stimulated genes (ISGs), including GBP2, IRF1, ISG20, and IFIT2, during both single PDCoV infection and co-infection with porcine epidemic diarrhea virus (PEDV) [32]. This transcriptional reprogramming underscores the host's attempt to establish an antiviral state. Critically, the interferon-stimulated gene 20 (ISG20) has been shown to exert a significant inhibitory effect on PDCoV replication in vitro, highlighting a specific and potent innate antiviral effector [32]. This suggests that the magnitude and efficacy of the early IFN response are crucial determinants of viral control.

The adaptive immune response, characterized by its specificity and memory, is essential for long-term protection and recovery. In conventionally weaned pigs experimentally infected with PDCoV, a robust and multi-faceted humoral response is elicited. Following primary challenge, pigs develop significantly increased titers of PDCoV-specific IgG, IgA, and virus-neutralizing (VN) antibodies in serum, alongside elevated levels of the Th1-associated cytokine IFN-γ [26]. The appearance of these antibodies correlates temporally with the resolution of clinical diarrhea and the cessation of viral shedding, typically by 21 days post-infection (dpi) [26]. The critical role of this adaptive response is further demonstrated by the complete protection observed upon re-challenge at 21 dpi, with serum levels of IgG, IgA, and VN antibodies increasing further, indicative of a robust anamnestic response [26]. Notably, the presence of PDCoV-specific IgA in saliva was also detected post-rechallenge, correlating well with serum titers, suggesting that mucosal immunity plays a significant role in protection [26]. This aligns with the enteric nature of the virus, where secretory IgA (sIgA) is the primary effector antibody at mucosal surfaces. The induction of neutralizing antibodies is particularly important, as they can directly block viral entry into host cells by targeting the spike (S) protein, which mediates attachment and membrane fusion.

Vaccine Development Strategies: From Traditional to Novel Platforms

The development of safe and effective vaccines against PDCoV is an urgent global priority, given the significant economic losses in the swine industry and the potential for cross-species transmission. Current efforts are exploring a diverse array of platforms, from traditional inactivated vaccines to cutting-edge recombinant vector and nucleic acid-based approaches.

1. Recombinant Live-Vector Vaccines: The Salmonella Delivery System

A particularly innovative strategy involves the use of attenuated Salmonella typhimurium as a live vector to deliver PDCoV antigens. This approach capitalizes on the natural ability of Salmonella to invade the gut-associated lymphoid tissue (GALT), thereby targeting the mucosal immune system directly, the primary site of PDCoV infection. Researchers have constructed an oral vaccine strain, SL7207 (pVAX1-S1), which carries a eukaryotic expression plasmid encoding the S1 subunit of the PDCoV spike protein [31]. The S1 domain is a prime target for neutralizing antibodies, making it an ideal antigenic candidate.

In murine models, oral immunization with SL7207 (pVAX1-S1) successfully induced a comprehensive immune response, including PDCoV-specific humoral IgG and IgA, neutralizing antibodies, and mucosal sIgA [31]. Crucially, it also elicited a cellular immune response, characterized by the upregulation of CD8+ T cells and increased levels of Th1 cytokines (IFN-γ and IL-2) [31]. When evaluated in piglets, the target species, the vaccine induced high levels of PDCoV-specific humoral IgG and neutralizing antibodies [31]. While the induction of serum IgA and mucosal sIgA was less pronounced than in mice, the vaccine still promoted T cell differentiation into both CD4+ and CD8+ T cells and increased the expression of IFN-γ and IL-4 in peripheral blood [31]. The ultimate test of efficacy came from challenge experiments, where vaccinated piglets exhibited significantly alleviated diarrhea, reduced fecal viral loads, and less severe intestinal lesions compared to control groups [31]. This work provides compelling proof-of-concept that an oral, Salmonella-based vaccine can stimulate protective immunity against PDCoV, offering a practical and cost-effective delivery method for large-scale swine operations.

2. Subunit and Protein-Based Vaccines

Subunit vaccines, which use specific immunogenic proteins rather than the whole pathogen, offer a high safety profile. The nucleocapsid (N) protein, being highly conserved and abundant, is a prime target for diagnostic assays and is also being explored for its immunogenic potential. The development of monoclonal antibody (mAb)-based competitive ELISAs (cELISA) and blocking ELISAs using recombinant N protein has been critical for serological surveillance, allowing for the detection of PDCoV antibodies with high sensitivity (97.44-98.79%) and specificity (96.34-100%) [4, 6]. While these assays are primarily diagnostic tools, the N protein itself can induce a humoral response. However, the S protein, particularly its S1 subunit, remains the primary focus for vaccine development due to its role in inducing neutralizing antibodies. The identification of 14 positively selected amino acid sites in the S protein, many located in regions related to viral attachment and receptor binding, underscores the need for vaccine antigens to be based on contemporary circulating strains to ensure broad coverage [1].

3. Advanced Diagnostic Platforms as a Foundation for Vaccinology

Robust diagnostics are the bedrock of effective vaccination campaigns, enabling the monitoring of herd immunity and the differentiation of infected from vaccinated animals (DIVA). Several advanced diagnostic tools have been developed alongside vaccine efforts. These include a quantum dot-based immunochromatographic strip (QD-ICS) for rapid, field-deployable detection of the N protein, achieving a 95% detection limit of 236.661 TCID50/mL and 96.7% concordance with RT-PCR [5]. Similarly, a reverse transcription recombinase-aided amplification combined with a lateral flow dipstick (RT-RAA-LFD) assay targeting the ORF1b gene can deliver results in just 11 minutes [20]. For high-throughput and differential diagnosis, multiplex qPCR assays and MALDI-TOF nucleic acid mass spectrometry (NAMS) platforms have been developed to simultaneously detect PDCoV alongside other major swine enteric pathogens like PEDV and TGEV, with high sensitivity and specificity [19, 28]. These tools are indispensable for evaluating vaccine efficacy in clinical trials and for implementing strategic vaccination programs.

Antiviral Strategies: Targeting the Virus and the Host

Beyond vaccination, the development of direct-acting antivirals (DAAs) and host-directed therapies (HDTs) provides additional layers of defense, particularly for outbreak control and treatment of infected animals.

1. Host-Directed Antivirals (HDAs): Exploiting the Integrated Stress Response

A promising HDA strategy targets the host's integrated stress response (ISR). Viruses, including coronaviruses, hijack the host cell's protein synthesis machinery for their own replication. The ISR is a cellular defense mechanism that, when activated, leads to the phosphorylation of eukaryotic translation initiation factor 2α (eIF2α), which globally shuts down protein synthesis, thereby starving the virus of the resources it needs. A recent study identified a new class of flavonoid-based compounds that act as ISR activators [18]. Lead compounds 1-B and 1-C were shown to potently inhibit both PEDV and PDCoV replication in vitro [18]. Mechanistic studies confirmed that these compounds exert their antiviral effect by upregulating eIF2α phosphorylation, which in turn downregulates global protein synthesis in host cells [18]. This approach is particularly attractive because it targets a host pathway, making it more difficult for the virus to develop resistance through mutation. This represents a significant step forward in the search for effective therapeutics against these economically devastating viruses.

2. Antibody-Based Therapeutics: Single-Chain Fragment Variable (scFv) Antibodies

Passive immunotherapy using monoclonal antibodies offers an immediate and specific antiviral effect. Phage display technology has been employed to generate a porcine single-chain fragment variable (scFv) antibody, N53, which specifically targets the PDCoV N protein [10]. The scFv N53 was successfully expressed as an Fc-fusion protein and purified. It was shown to bind to the N protein with high affinity, and its minimal epitope was mapped to amino acid residues 82GELPPNDTPATTRVT96 [10]. While N53 targets the N protein, which is internal and not a target for neutralization, this work provides a critical platform and methodology for generating scFv antibodies against other, more accessible targets like the S protein. Such antibodies could be developed as therapeutic reagents for treating severe PDCoV infections, particularly in valuable breeding stock or during acute outbreaks in neonatal piglets.

In conclusion, the fight against PDCoV is being waged on multiple fronts. The host immune response, particularly the induction of neutralizing antibodies and mucosal IgA, provides a clear roadmap for vaccine development. Innovative platforms like oral Salmonella-vectored vaccines show great promise for inducing protective immunity at the site of infection. Concurrently, the discovery of host-directed antivirals that exploit the integrated stress response offers a novel and potentially resistance-proof therapeutic strategy. The continued integration of advanced diagnostics, evolutionary biology, and immunology will be essential to stay ahead of this rapidly evolving virus and to safeguard both animal and human health.

References

[1] Guo Z, Lu Q, Jin Q, Li P, Xing G, Zhang G. Phylogenetically evolutionary analysis provides insights into the genetic diversity and adaptive evolution of porcine deltacoronavirus. BMC Veterinary Research. 2024. DOI: https://doi.org/10.1186/s12917-023-03863-2

[2] Hsueh F, Hsu F, Chen Y, Shih H, Lin W, Yang C, et al.. Phylogenetic Classification of Global Porcine Deltacoronavirus (PDCoV) Reference Strains and Molecular Characterization of PDCoV in Taiwan. Viruses. 2021. DOI: https://doi.org/10.3390/v13071337

[3] Li B, Gao Y, Ma Y, Shi K, Shi Y, Feng S, et al.. Genetic and Evolutionary Analysis of Porcine Deltacoronavirus in Guangxi Province, Southern China, from 2020 to 2023. Microorganisms. 2024. DOI: https://doi.org/10.3390/microorganisms12020416

[4] Wang W, Fan B, Zhang X, Yang S, Zhou J, Guo R, et al.. Development and evaluation of a monoclonal antibody-based competitive ELISA for detecting porcine deltacoronavirus antibodies. Animal Diseases. 2024. DOI: https://doi.org/10.1186/s44149-024-00137-8

[5] Liu M, Huang H, Gao P, Zhou Q, Zhou L, Ge X, et al.. A quantum dot-based double-antibody sandwich immunochromatographic strip for rapid detection of porcine deltacoronavirus targeting the nucleocapsid protein.. Microbial Pathogenesis. 2025. DOI: https://doi.org/10.1016/j.micpath.2025.108152

[6] Wang W, Zhang Y, Yang H. Development of a Nucleocapsid Protein-Based Blocking ELISA for the Detection of Porcine Deltacoronavirus Antibodies. Viruses. 2022. DOI: https://doi.org/10.3390/v14081815

[7] Wang H, Qin Y, Zhao W, Yuan T, Yang C, Mi X, et al.. Genetic Characteristics and Pathogenicity of a Novel Porcine Deltacoronavirus Southeast Asia-Like Strain Found in China. Frontiers in Veterinary Science. 2021. DOI: https://doi.org/10.3389/fvets.2021.701612

[8] Wang G, Li L, Chen J, Wang Q, Ye R, Li L, et al.. Emergence of a Novel Genotype of Pigeon Deltacoronavirus Closely Related to Porcine Deltacoronavirus HKU15 and Sparrow Deltacoronavirus HKU17 in a Live Poultry Market in Shandong Province, China. Microbiology spectrum. 2023. DOI: https://doi.org/10.1128/spectrum.00556-23

[9] Zhao Y, Qu H, Hu J, Fu J, Chen R, Li C, et al.. Characterization and Pathogenicity of the Porcine Deltacoronavirus Isolated in Southwest China. Viruses. 2019. DOI: https://doi.org/10.3390/v11111074

[10] Zhang Y, Song Y, Ren H, Zeng Q, Yuan Y, Xia L, et al.. Preparation of a Single-Chain Antibody against Nucleocapsid Protein of Porcine Deltacoronavirus by Phage Display Technology. Viruses. 2022. DOI: https://doi.org/10.3390/v14040772

[11] More-Bayona J, Ramirez-Velasquez M, Hause B, Nelson E, Rivera-Geronimo H. First isolation and whole genome characterization of porcine deltacoronavirus from pigs in Peru. Transboundary and Emerging Diseases. 2021. DOI: https://doi.org/10.1111/tbed.14489

[12] Zhang Y, Cheng Y, Xing G, Yu J, Liao A, Du L, et al.. Detection and spike gene characterization in porcine deltacoronavirus in China during 2016–2018. Infection, Genetics and Evolution. 2019. DOI: https://doi.org/10.1016/j.meegid.2019.04.023

[13] Janetanakit T, Lumyai M, Bunpapong N, Boonyapisitsopa S, Chaiyawong S, Nonthabenjawan N, et al.. Porcine Deltacoronavirus, Thailand, 2015. Emerging Infectious Diseases. 2016. DOI: https://doi.org/10.3201/eid2204.151852

[14] Bayona JM, rez MR, Hause BM, Rivera H. The first isolation and whole genome characterization of Porcine Deltacoronavirus from pigs in Peru. . 2020. DOI: https://doi.org/10.22541/au.159129007.73778329

[15] Chu K, Zhou Z, Wang Q, Ye S, Guo L, Qiu Y, et al.. Characterization of Deltacoronavirus in Black-Headed Gulls (Chroicocephalus ridibundus) in South China Indicating Frequent Interspecies Transmission of the Virus in Birds. Frontiers in Microbiology. 2022. DOI: https://doi.org/10.3389/fmicb.2022.895741

[16] McCluskey B, Haley C, Rovira A, Main R, Zhang Y, Barder S. Retrospective testing and case series study of porcine delta coronavirus in U.S. swine herds. Preventive Veterinary Medicine. 2015. DOI: https://doi.org/10.1016/j.prevetmed.2015.10.018

[17] Duan C, Luo Y, Liang X, Wang X. A Review of Bioactive Compounds against Porcine Enteric Coronaviruses. Viruses. 2022. DOI: https://doi.org/10.3390/v14102217

[18] Yi L, Wang Y, Wang J, Chen Y, Huang W, Liao Y, et al.. Targeting host integrated stress response: lead discovery of flavonoid compounds active against coronaviruses PEDV and PDCoV.. RSC Medicinal Chemistry. 2024. DOI: https://doi.org/10.1039/d4md00846d

[19] Chen J, Liu R, Liu H, Chen J, Li X, Zhang J, et al.. Development of a Multiplex Quantitative PCR for Detecting Porcine Epidemic Diarrhea Virus, Transmissible Gastroenteritis Virus, and Porcine Deltacoronavirus Simultaneously in China. Veterinary Sciences. 2023. DOI: https://doi.org/10.3390/vetsci10060402

[20] Zeng J, Wang W, Zhou L, Ge X, Han J, Guo X, et al.. A nucleic acid detection assay combining reverse transcription recombinase-aided amplification with a lateral flow dipstick for the rapid visual detection of porcine deltacoronavirus. Virulence. 2022. DOI: https://doi.org/10.1080/21505594.2022.2116157

[21] El-Tholoth M, Bai H, Mauk M, Saif L, Bau H. A portable, 3D printed, microfluidic device for multiplexed, real time, molecular detection of the porcine epidemic diarrhea virus, transmissible gastroenteritis virus, and porcine deltacoronavirus at the point of need.. Lab on a Chip. 2021. DOI: https://doi.org/10.1039/d0lc01229g

[22] Feng Y, Xu Z, Zhu L. Prevalence and phylogenetic analysis of porcine deltacoronavirus in Sichuan province, China. Archives of Virology. 2020. DOI: https://doi.org/10.1007/s00705-020-04796-z

[23] Anderson T, Inderski B, Diel D, Hause B, Porter E, Clement T, et al.. The United States Swine Pathogen Database: integrating veterinary diagnostic laboratory sequence data to monitor emerging pathogens of swine. bioRxiv. 2021. DOI: https://doi.org/10.1093/database/baab078

[24] Trevisan G, Linhares L, Schwartz K, Burrough ER, Magalhães E, Crim B, et al.. Data standardization implementation and applications within and among diagnostic laboratories: integrating and monitoring enteric coronaviruses. Journal of Veterinary Diagnostic Investigation. 2021. DOI: https://doi.org/10.1177/10406387211002163

[25] Li D, Feng H, Liu YC, Chen Y, Wei Q, Wang J, et al.. Molecular evolution of porcine epidemic diarrhea virus and porcine deltacoronavirus strains in Central China. Research in Veterinary Science. 2018. DOI: https://doi.org/10.1016/j.rvsc.2018.06.001

[26] Zhao D, Gao X, Zhou P, Zhang L, Zhang Y, Wang Y, et al.. Evaluation of the immune response in conventionally weaned pigs infected with porcine deltacoronavirus. Archives of Virology. 2020. DOI: https://doi.org/10.1007/s00705-020-04590-x

[27] Sun M, Li T, Liu W, Guo Z, Wang Z, Jiang J, et al.. Severe Diarrhea Outbreaks in Newborn Piglets in China Associated With Porcine Rotavirus B. Transboundary and Emerging Diseases. 2025. DOI: https://doi.org/10.1155/tbed/5588912

[28] Shuai J, Song S, Han X, Zhao Y, Chen K, Guo Y, et al.. Multiplex detection and application of MALDI-TOF NAMS for porcine diarrheal pathogens. Microbiology spectrum. 2025. DOI: https://doi.org/10.1128/spectrum.01328-25

[29] Zhang Y, Li Q, Si L, Gao J, Yuan J, Xia L, et al.. Isolation and Characterization of Porcine Sapelovirus from the PDCoV-Positive Sample and Its Molecular Epidemiology in Henan Province, China. Transboundary and Emerging Diseases. 2023. DOI: https://doi.org/10.1155/2023/9943040

[30] Kubacki J, Fraefel C, Bachofen C. Implementation of next-generation sequencing for virus identification in veterinary diagnostic laboratories. Journal of Veterinary Diagnostic Investigation. 2020. DOI: https://doi.org/10.1177/1040638720982630

[31] Yang J, Chen R, Sun M, Yuan R, Xiao Y, Sun Y, et al.. Development and immunogenicity evaluation of attenuated Salmonella typhimurium delivering porcine Deltacoronavirus S1 gene.. International Journal of Biological Macromolecules. 2024. DOI: https://doi.org/10.1016/j.ijbiomac.2024.138615

[32] Lu Y, Yu R, Tong L, Zhang L, Zhang Z, Pan L, et al.. Transcriptome Analysis of LLC-PK Cells Single or Coinfected with Porcine Epidemic Diarrhea Virus and Porcine Deltacoronavirus. Viruses. 2023. DOI: https://doi.org/10.3390/v16010074